Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence
pharmaphorum
NOVEMBER 25, 2022
The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. And so, pharmaceutical spending is an investment, he said.
Let's personalize your content